Rigel stock soars after FDA approves leukemia treatment, 2 days after receiving delisting notice

Retrieved on: 2022-12-02 14:37:10

Tags for this article:

Click the tags to see associated articles and topics

Rigel stock soars after FDA approves leukemia treatment, 2 days after receiving delisting notice. View article details on hiswai:

Excerpt

Shares of Rigel Pharmaceuticals Inc. undefined soared 39.5% in premarket trading Friday, after the biotechnology company announced Food and Drug.

Article found on: www.marketwatch.com